Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-19-021040
Filing Date
2019-10-24
Accepted
2019-10-24 18:55:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT f424b3102319_relmadatherap.htm 424B3 1286310
  Complete submission text file 0001213900-19-021040.txt   1287358
Mailing Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-233228 | Film No.: 191166837
SIC: 2834 Pharmaceutical Preparations